Martha Goldberg Aronson - Jun 2, 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Martha Goldberg Aronson by Power of Attorney
Stock symbol
CNMD
Transactions as of
Jun 2, 2025
Transactions value $
$0
Form type
4
Date filed
6/4/2025, 05:29 PM
Previous filing
Jun 4, 2024
Next filing
Oct 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aronson Martha Goldberg Director C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO /s/ Thomas Fistek for Martha Goldberg Aronson by Power of Attorney 2025-06-04 0001429832

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +479 +4.02% $0.00 12.4K Jun 3, 2025 Direct
holding CNMD Common Stock 2K Jun 2, 2025 by IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Award $0 +8.06K $0.00 8.06K Jun 2, 2025 Common Stock 8.06K $55.38 Direct F1
transaction CNMD RSUs (Restricted Stock Units) Award $0 +668 $0.00 668 Jun 2, 2025 Common Stock 668 $0.00 Direct F2
transaction CNMD RSUs (Restricted Stock Units) Options Exercise $0 -479 -100% $0.00 0 Jun 3, 2025 Common Stock 479 $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.